Why is endometriosis not considered cancer

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Endometriosis is not considered cancer because it lacks the key characteristics of malignancy: it does not invade surrounding tissues destructively or metastasize to distant organs. While endometriosis affects approximately 10% of reproductive-age women worldwide (about 190 million), it remains a benign condition where endometrial-like tissue grows outside the uterus. Unlike cancers, which show uncontrolled cell proliferation and genetic mutations driving metastasis, endometriosis lesions typically grow in a controlled manner and respond to hormonal cycles. The distinction was formally recognized in medical classifications by the early 20th century, with the World Health Organization categorizing it separately from gynecological cancers.

Key Facts

Affects approximately 10% of reproductive-age women globally (about 190 million people)
First described medically by Karl von Rokitansky in 1860
Typically diagnosed in women aged 25-35 years, with average diagnostic delay of 7-10 years
Associated with chronic pelvic pain in 70-80% of cases and infertility in 30-50% of affected women
Treatment often involves hormonal therapies (like GnRH agonists) or laparoscopic surgery, with recurrence rates of 20-40% within 5 years post-surgery

Overview

Endometriosis is a chronic gynecological condition where tissue similar to the uterine lining (endometrium) grows outside the uterus, commonly on pelvic organs like ovaries, fallopian tubes, and the peritoneum. First medically described by Austrian pathologist Karl von Rokitansky in 1860, it was historically misunderstood as "adenomyosis externa" before being named endometriosis in the 1920s. The condition affects an estimated 190 million women and girls globally during their reproductive years, with prevalence studies showing rates of 6-10% in the general female population. Despite its high prevalence, diagnosis remains challenging, with an average delay of 7-10 years from symptom onset to confirmed diagnosis. The economic burden is substantial, with annual healthcare costs in the United States alone exceeding $20 billion when accounting for direct medical expenses and lost productivity.

How It Works

Endometriosis develops through several proposed mechanisms, with retrograde menstruation being the most widely accepted theory. During menstruation, endometrial cells flow backward through the fallopian tubes into the pelvic cavity instead of exiting the body, where they implant and grow on pelvic structures. These ectopic lesions respond to hormonal fluctuations during menstrual cycles, causing inflammation, bleeding, and formation of scar tissue (adhesions). Unlike cancerous tumors, endometriosis lesions do not exhibit malignant transformation markers such as uncontrolled mitosis, tissue invasion beyond implantation sites, or metastasis to distant organs. The condition creates a pro-inflammatory environment with elevated cytokines and growth factors, but cellular atypia and genetic instability characteristic of cancers are absent. Diagnosis typically involves laparoscopic visualization of lesions, with histological confirmation showing endometrial-like glands and stroma without malignant features.

Why It Matters

Understanding why endometriosis isn't cancer has crucial implications for patient care and research. This distinction affects treatment approaches: while cancers often require aggressive interventions like chemotherapy or radiation, endometriosis management focuses on symptom control through hormonal therapies, pain management, and conservative surgery. Misclassification could lead to overtreatment with unnecessary radical procedures. The benign nature also influences research priorities, with studies emphasizing inflammation regulation rather than oncogenic pathways. For patients, this clarification helps alleviate cancer-related anxiety while highlighting the need for dedicated research into endometriosis-specific treatments, as current options often provide incomplete relief. Recognizing it as a distinct chronic condition has spurred advocacy efforts, leading to increased research funding and improved diagnostic guidelines in recent decades.